However, while UCHL1 and FABP3 appeared to be specific for AD, PKM activity increased in both AD and FTD patients, underlining that these two diseases may share alterations of energy metabolism that should be further explored as candidate pathways involved in dementia. Here, PKM is linked to Alzheimer disease.